CRVS
Corvus Pharmaceuticals Inc
11.60$
-1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +301.4% | +41.8% | +0.6% | -12.3% | -14.9% | -27.2% | -20.2% | -58.9% | -43.7% | +23.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27,283.9% | +158.6% | +57.7% | -16.7% | -1.6% | -16.2% | -8.5% | -16.0% | -32.5% | +17.3% | +73.9% | |
| – | +1,702.0% | +215.1% | +34.1% | +4.1% | +2.3% | +9.7% | -20.2% | -14.9% | -15.0% | +18.6% | +13.3% | |
| – | +7,740.1% | +168.5% | +52.9% | -12.9% | -0.7% | -10.4% | -11.7% | -15.7% | -28.1% | +17.7% | +55.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | -4.4% | -75.3% | -97.2% | +4,260.0% | +142.2% | +15.2% | +37.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -228.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -213,184.2% | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.